A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models.
More in Research
This “rare” autism-linked genetic disorder may be far more common than scientists thought
September 25, 2026
CRISPR could help doctors attack blood cancer without destroying healthy cells
September 25, 2026
CERN has begun disconnecting the Large Hadron Collider
September 25, 2026
Quantum computing’s “dark horse” just proved it can go universal
September 25, 2026
Earth is tearing apart beneath the Pacific Northwest
September 25, 2026
Scientists gave worms magnetic bacteria. They lived 43% longer
September 25, 2026
Latest News
IND vs WI: இந்திய அணியில் கடும் போட்டி இருக்கு.. இவருக்கு வாய்ப்பு கிடைப்பது கடினம்.. ஷிட்டான்சு கோடாக்
September 26, 2026
2027 உலககோப்பை உடன் ஓய்வு என்று சொன்னாரா விராட் கோலி? உண்மை என்ன?
September 26, 2026
Burnham announces scheme to help first-time buyers onto housing ladder
September 26, 2026
IIT-Madras deep tech fund achieves ₹450 crore first close
September 26, 2026
'It's a big moment! | Putellas nets her first goal for London City
September 26, 2026
OpenAI pauses training of its ‘most capable models’
September 26, 2026